Expression of caveolin-1 and caveolin-2 in the human pituitary: An immunohistochemical study

Endocrine Pathology

Volumn 15, Issue 4, 2004, Pages 345-350

  Rotondo, Fabio ^a   Horvath, Eva ^a   Kovacs, Kalman ^a   Bell, David C ^a   Lloyd, Ricardo V ^b   Scheithauer, Bernd W ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

Caveolin; Immunohistochemistry; Pathology; Pituitary; Pituitary neoplasm

Indexed keywords

BIOTIN; BLOOD CLOTTING FACTOR 8; CAVEOLIN 1; CAVEOLIN 2; CD34 ANTIGEN; PEROXIDASE; STREPTAVIDIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARY; CAVEOLA; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE LOCATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN TRANSPORT; TUMOR CELL; ULTRASTRUCTURE;

ADENOMA; ADENOMA, OXYPHILIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAVEOLIN 1; CAVEOLIN 2; CAVEOLINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 13444249641     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:4:345     Document Type: Article

References (28)

1. Gumbleton M, Abulrob AG, Campbell L. Caveolae: an alternative membrane transport compartment. Pharm Res 17:1035-1048, 2000.
2. Campbell L, Gumbleton M, Ritchie K. Caveolae and the caveolins in human disease. Adv Drug Deliv Rev 49:325-335, 2001.
3. Couet J, Belanger MM, Roussel E, Drolet MC. Cell biology of caveolae and caveolin. Adv Drug Del Rev 49:223-235, 2001.
4. Matveev S, Li X, Everson W, Smart EJ. The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Adv Drug Deliv Rev 49:237-250, 2001.
5. Razani B, Lisanti MP. Caveolins and caveolae: molecular and functional relationships. Exp Cell Res 271:36-44, 2001.
6. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431-467, 2002.
7. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13:92-100, 2003.
8. Fra AM, Mastroianni N, Mancini M, Pasqualetto E, Sitia R. Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors. Genomics 56:355-356, 1999.
9. Engelman JA, Zhang XL, Galbiati F, Lisanti MP. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2 and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 429:330-336, 1998.
10. Tang Z, Scherer PE, Okamoto T, et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261, 1996.
11. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682, 1992.
12. Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP. Angiogenesis activators and inhibitors differentially regulate caveolin expression and caveola formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J Biol Chem 274:15781-15785, 1999.
13. Kifor O, Kifor I, Moore FD Jr, et al. Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas. J Clin Endocrinol Metab 88:4455-4464, 2003.
14. Morgan MB, Stevens GL, Tannenbaum M, Salup R. Expression of the caveolins in dermal vascular tumors. J Cutan Pathol 28:24-28, 2001.
15. Kovacs K, Lloyd RV, Horvath E, et al. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination and in situ hybridization. Am J Pathol 134:345-353, 1989.
16. Kovacs K, Stefaneanu L, Horvath E, et al. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch (A) Pathol Anat Histopathol 418:439-446, 1991.
17. Vidal S, Horvath E, Kovacs K, Lloyd RV, Smyth HS. Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia. Mod Pathol 14:20-28, 2001.
18. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 78:502-510, 1996.
19. Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev 49:317-323, 2001.
20. Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60:5870-5878, 2000.
21. Bender F, Montoya M, Monardes V, Leyton L, Quest AF. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 35:151-167, 2002.
22. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391-1397, 1998.
23. Racine C, Belanger M, Hirabayashi H, Boucher M, Chakir J, Couet J. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun 255:580-586, 1999.
24. Wiechen K, Diatchenko L, Agoulnik A, et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159:1635-1643, 2001.
25. Engelman JA, Zhang X, Galbiati F, et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 63:1578-1587, 1998.
26. Razani B, Schlegel A, Liu J, Lisanti MP. Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans 29:494-499, 2001.
27. Minshall RD, Tiruppathi C, Vogel SM, Malik AB. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 117:105-112, 2002.
28. Park WY, Cho KA, Park JS, Kim DI, Park SC. Attenuation of EGF signaling in senescent cells by caveolin. Ann NY Acad Sci 928:79-84, 2001.